Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome

Indian Journal of Nephrology

Volumn 23, Issue 1, 2013, Pages 41-46

  Sinha, A ^a   Sharma, A ^a   Mehta, A ^a   Gupta, R ^a   Gulati, A ^a   Hari, P ^a   Dinda, A K ^a   Bagga, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cyclosporine; Focal segmental glomerulosclerosis; Tacrolimus

Indexed keywords

CYCLOSPORIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTERIOLE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; HYPERTENSION; INFANT; JUXTAGLOMERULAR APPARATUS; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; NEPHROTIC SYNDROME; NEPHROTOXICITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROTEINURIA; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM;

EID: 84875716193     PISSN: 09714065     EISSN: 19983662     Source Type: Journal    
DOI: 10.4103/0971-4065.107197     Document Type: Article

References (34)

1. Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev 2008;1:CD002290.
2. Gulati A, Bagga A, Gulati S, Mehta K, Vijaykumar M. For the Indian society of pediatric nephrology. Guidelines for management of children with steroid resistant nephrotic syndrome. Indian Pediatr 2009;46:35-47.
3. Singh A, Tejani C, Tejani A. One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 1999;13:26-32.
4. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: A randomized controlled trial. Am J Kidney Dis 2009;53:760-9.
5. Hulton SA, Jadresic L, Shah V, Trompeter RS, Dillon MJ, Barratt TM. Effect of cyclosporine A on glomerular filtration rate in children with minimal change nephrotic syndrome. Pediatr Nephrol 1994;8:404-7.
6. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, et al. long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: A single-centre experience. Nephrol Dial Transplant 2005;20:2433-8.
7. Butani L, Ramsamooj R. Experience with tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 2009;24:1517-23.
8. Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y. Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 2006;91:666-70.
9. Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, et al. Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 2002;61:1801-5.
10. Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, et al. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol 2009;4:1409-16.
11. Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children. Kidney Int 1981;20:765-71.
12. Mihatsch MJ, Antonovych T, Bohman SO, Habib R, Helmchen U, Noel LH, et al. Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies. Clin Nephrol 1994;41:23-32.
13. Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol 2007;2:135-42.
14. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, et al. long-term cyclosporine therapy for pediatric nephrotic syndrome: A clinical and histologic analysis. J Am Soc Nephrol 1996;7:543-9.
15. Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, et al. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 2009;24:2177-85.
16. Morgan C, Sis B, Pinsk M, Yiu V. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Nephrol Dial Transplant 2011;26:2860-5.
17. Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, et al. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. Am J Kidney Dis 1998;31:932-9.
18. Falkenhain ME, Cosio FG, Sedmak DD. Progressive histologic injury in kidneys from heart and liver transplant recipients receiving CyA. Transplantation 1996;62:364-70.
19. Ruiz P, Kolbeck PC, Scroggs MW, Sanfilippo F. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 1988;45:91-5.
20. Broor P, Sebekova K, Ostendorf T, Floege J. Treatment targets in renal fibrosis. Nephrol Dial Transplant 2007;22:3391-407.
21. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. Pediatr Nephrol 2003;18:351-6.
22. Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis. Pediatr Nephrol 1999;13:113-6.
23. Klein IH, Abrahams A, van Ede T, Hené RJ, Koomans HA, Ligtenberg G. Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. Transplantation 2002;73:732-6.
24. Jain S, Bicknell GR, Nicholson ML. Tacrolimus has less fibrogenic potential than cyclosporin A in a model of renal ischaemia-reperfusion injury. Br J Surg 2000;87:1563-8.
25. Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group. Transplantation 1998;66:1736-40.
26. Martins L, Ventura A, Branco A, Carvalho MJ, Henriques AC, Dias L, et al. Cyclosporine versus tacrolimus in kidney transplantation: Are there differences in nephrotoxicity? Transplant Proc 2004;36:877-9.
27. Coates PT. Nephrotoxicity and calcineurin inhibitors. Nephrology 2007;12:S85-7.
28. Horike K, Takeda A, Yamaguchi Y, Ogiyama Y, Yamauchi Y, Murata M, et al. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity? Clin Transplant 2011;25:23-7.
29. Sharma A, Jain S, Gupta R, Guleria S, Agarwal S, Dinda A. Calcineurin inhibitor toxicity in renal allografts: Morphologic clues from protocol biopsies. Indian J Pathol Microbiol 2010;53:651-7.
30. Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R. long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatr Nephrol 2000;14:214-7.
31. Sinha MD, MacLeod R, Rigby E, Clark AG. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant 2006;21:1848-54.
32. Kranz B, Vester U, Büscher R, Wingen AM, Hoyer PF. Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years. Pediatr Nephrol 2008;23:581-6.
33. Gipson DS, Trachtman H, Kaskel FJ, Greene TH, Radeva MK, Gassman JJ, et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int 2011;80:868-78.
34. Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, et al. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome. Kidney Int 0; 82:1130-5.